Healthcare -
Biotechnology - NASDAQ - US
$ 79.05
-3.07 %
$ 14.3 B
Market Cap
-14.19
P/E
INSM - COST OF REVENUE
Cost of Revenue INSM - Insmed Incorporated
85.7 M
LAST VALUE
24.71%
2 YEAR CAGR
28.78%
5 YEAR CAGR
9.84%
10 YEAR CAGR